| PERIOD ENDING | 30-Sep-09 | 30-Jun-09 | 31-Mar-09 | 31-Dec-08 | | Total Revenue | 364,853 | 373,585 | 437,109 | 410,080 | | Cost of Revenue | 320,910 | 327,257 | 386,511 | 352,972 | | | Gross Profit | 43,943 | 46,328 | 50,598 | 57,108 | | | Operating Expenses | | Research Development |
-
|
-
|
-
|
-
| | Selling General and Administrative | 25,631 | 30,320 | 30,779 | 40,140 | | Non Recurring |
-
|
-
|
-
|
-
| | Others |
-
|
-
|
-
|
-
| | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | 18,312 | 16,008 | 19,819 | 16,968 | | | Income from Continuing Operations | | Total Other Income/Expenses Net | 2,988 | 1,494 | 733 | (3,665) | | Earnings Before Interest And Taxes | 21,300 | 17,502 | 20,552 | 13,303 | | Interest Expense | 6,368 | 7,465 | 7,956 | 12,552 | | Income Before Tax | 14,932 | 10,037 | 12,596 | 751 | | Income Tax Expense | 1,742 | 2,351 | 4,274 | (2,066) | | Minority Interest | (334) | (356) | (195) | (426) | | | | Net Income From Continuing Ops | 12,856 | 7,330 | 8,127 | 2,391 | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | 12,856 | 7,330 | 8,127 | 2,391 | | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | | Net Income Applicable To Common Shares | $12,856 | $7,330 | $8,127 | $2,391 |
|
0.11% Nasdaq 0.00%
Income Statement
